Based on our experience, it’s a claim we can make with 100% certainty. Since 2019, when ProxsysRx launched its 340B Support Services division, we’ve managed the 340B programs of 18 health systems. Altogether, we’ve generated more than $435 million in 340B Savings and Revenue for those health systems — $98M in the first 10 months … Read More
Just ask her, she’ll admit it: When Shequila worked at ProxsysRx’s Conway Medical Center (CMC) pharmacy, her boss had a habit of talking about her to other people in the company. Which explains why she got an email one day from Dawn Dobersztyn, asking, “Have you seen this job opening we just posted?” Seems that … Read More
ProxsysRx recently gathered three of its corporate executives for an in-depth discussion of how an eligible health system can optimize revenues from its 340B program and its retail pharmacy, to help build and fund an onsite specialty pharmacy. Below is a lightly-edited transcript of that discussion. NOTE: If you’d prefer to watch the complete video … Read More
Few corporate ladders in the retail pharmacy world rise higher than Derel Smith’s did. As former Director of Pharmacy Operations for a major regional retailer, he managed oversight of nearly 600 pharmacies. It was a position nearly 30 years in the making, and one that afforded him an enviable lifestyle in Orlando. So why, you’d … Read More
To date, we’ve published a dozen posts either detailing, or mentioning-in-passing, the clinical and financial benefits a well-run Meds To Beds program offers hospitals and the patients they serve. Which is why we thought it was time to report some of the personal benefits our program delivers — with a handful of stories we’ve heard … Read More
Why a Specialty Pharmacy? (Overview) As chronic illnesses become increasingly common in the United States, the number of specialty medications for managing these conditions has skyrocketed. According to a report by The American Hospital Association, the number of Americans with chronic medical conditions will grow by a projected 9% between 2020 and 2030, an increase … Read More
In the past week, no less than three articles have called attention to the restrictions drug manufacturers have imposed to evade their legal responsibility to honor 340B program prescription discounts — as well as the impact those restrictions have had on 340B-eligible nonprofit entities’ ability to serve their patients and communities. “Don’t believe drug companies: … Read More
(Photo above: ProxsysRx’s pharmacy at Terrebonne General Health System, in Houma, LA) The Retail Component “Dawn Dobersztyn does not get enough credit,” says ProxsysRx COO Billy Calhoun. “When you think about it, retail is the face of our pharmacies. It’s the first thing people see when they walk in the door. And here’s the thing: … Read More
On June 12, ProxsysRx opened its pharmacy in Holyoke Medical Center — a 198-bed independent community hospital in Holyoke, Massachusetts. The pharmacy is currently offering full retail service, and some patient-discharge prescription support (Meds To Beds), but the Employee Prescription plan still has a few hurdles to overcome. It’s a still-unfinished process that began when … Read More
In late 2022, ProxsysRx’s team initiated 340B Program-Management support for a 198-bed, full-service, community and regional non-profit medical center located in the Northeast. After weeks of laying all the necessary groundwork to manage its 340B program, we began actively submitting eligible prescriptions this past January. By the end of Q1, the hospital’s 2023 340B savings … Read More
